The Potential Role of Changes in the Glucose and Lipid Metabolic Pathways in Gastrointestinal Cancer Progression: Strategy in Cancer Therapy.

IF 0.8 Q4 GASTROENTEROLOGY & HEPATOLOGY Gastrointestinal Tumors Pub Date : 2021-08-05 eCollection Date: 2021-10-01 DOI:10.1159/000517771
Gordon A Ferns, Milad Shahini Shams Abadi, Ahmad Raeisi, Mohammad-Hassan Arjmand
{"title":"The Potential Role of Changes in the Glucose and Lipid Metabolic Pathways in Gastrointestinal Cancer Progression: Strategy in Cancer Therapy.","authors":"Gordon A Ferns,&nbsp;Milad Shahini Shams Abadi,&nbsp;Ahmad Raeisi,&nbsp;Mohammad-Hassan Arjmand","doi":"10.1159/000517771","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Changes in cell metabolism are a well-known feature of some cancers, and this may be involved in the etiology of tumor formation and progression, as well as tumor heterogeneity. These changes may affect fatty acid metabolism and glycolysis and are required to provide the increase in energy necessary for the high rate of proliferation of cancer cells. Gastrointestinal cancers remain a difficult-to-treat cancer, particularly as they are usually diagnosed at a late stage of disease and are associated with poor outcomes.</p><p><strong>Summary: </strong>Recently, the changes in the metabolic pathways, including the expression of the rate-limiting enzymes involved, have been considered to be a potential target for therapy for gastrointestinal tumors.</p><p><strong>Key message: </strong>A combination of routine chemotherapy drugs with metabolic inhibitors may improve the effectiveness of treatment.</p>","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"8 4","pages":"169-176"},"PeriodicalIF":0.8000,"publicationDate":"2021-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000517771","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gastrointestinal Tumors","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000517771","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/10/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Changes in cell metabolism are a well-known feature of some cancers, and this may be involved in the etiology of tumor formation and progression, as well as tumor heterogeneity. These changes may affect fatty acid metabolism and glycolysis and are required to provide the increase in energy necessary for the high rate of proliferation of cancer cells. Gastrointestinal cancers remain a difficult-to-treat cancer, particularly as they are usually diagnosed at a late stage of disease and are associated with poor outcomes.

Summary: Recently, the changes in the metabolic pathways, including the expression of the rate-limiting enzymes involved, have been considered to be a potential target for therapy for gastrointestinal tumors.

Key message: A combination of routine chemotherapy drugs with metabolic inhibitors may improve the effectiveness of treatment.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
胃肠道肿瘤进展中糖脂代谢途径变化的潜在作用:癌症治疗策略
背景:细胞代谢的改变是一些癌症的一个众所周知的特征,这可能涉及肿瘤形成和进展的病因学,以及肿瘤的异质性。这些变化可能会影响脂肪酸代谢和糖酵解,并且需要为癌细胞的高增殖率提供必要的能量增加。胃肠道癌症仍然是一种难以治疗的癌症,特别是因为它们通常在疾病的晚期才被诊断出来,并且与不良预后有关。摘要:近年来,代谢途径的改变,包括相关限速酶的表达,被认为是胃肠道肿瘤治疗的潜在靶点。关键信息:常规化疗药物与代谢抑制剂的联合可能会提高治疗的有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Gastrointestinal Tumors
Gastrointestinal Tumors GASTROENTEROLOGY & HEPATOLOGY-
自引率
0.00%
发文量
5
审稿时长
17 weeks
期刊最新文献
Investigation of Novel Urinary Biomarkers in Hepatocellular Carcinoma Risk in a Predominantly African American Population: A Case-Control Study. Real-World Outcomes of FLOT versus CROSS Regimens for Patients with Oesophagogastric Cancers. Association between Serum Zinc Levels and Clinicopathological Characteristics in Patients with Gastric Cancer. Mixed Neuroendocrine and Non-Neuroendocrine Neoplasm of Pancreas: What Do We Know, What Have We Learnt? Mast Cell Sarcoma of Small Intestine, Early Diagnosis, and Good Prognosis: An Extremely Rare Case Report and Review of the Literature.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1